{
    "code": "02025081",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025081",
    "time": "2016-11-04 03:05:45",
    "許可證字號": "衛署藥輸字第025081號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/08\/20",
    "發證日期": "98\/08\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202508104",
    "中文品名": "英特萊錠 100 毫克",
    "英文品名": "Intelence Tablets 100mg",
    "適應症": "Intelence 與抗反轉錄病毒藥物併用，適用於曾有抗病毒藥物治療經驗，對過去的治療無效，且對NNTRI及其他抗反轉錄病毒藥物產生抗藥性之愛滋病毒HIV-1感染之成人患者。",
    "劑型": "110錠劑",
    "包裝": "4-1000 錠塑膠瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "ETRAVIRINE"
    ],
    "限制項目": "02輸　入 5A本品係依本署93年05月05日衛署藥字第0930309777號公告經本署認定得免除銜接性試驗，且經本署核定之新藥",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F250332000  JANSSEN-CILAG S.P.A.",
        "製造廠廠址": "VIA C. JANSSEN 04100 BORGO S. MICHELE-LATINA, ITALY",
        "製造廠公司地址": "VIA M. BUONARROTI 23 20093 COLOGNO MONZESE ITALY",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司(委託包裝)",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "貼標廠"
        },
        {
            "製造廠名稱": "F050069000  JANSSEN PHARMACEUTICA N.V.",
            "製造廠廠址": "JANSSEN PHARMACEUTICALAAN 3, B-2440 GEEL, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": "中間體製造"
        },
        {
            "製造廠名稱": "F460629000  TIBOTEC INC.",
            "製造廠廠址": "1020 STONY HILL ROAD, SUITE 300, YARDLEY, PA 19067, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818004000",
            "成分名稱": "ETRAVIRINE",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "[打樣版]PI_Intelence_Tab 100mg_EUPI Mar2016_v1602-105-09-19.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025081&Seq=005&Type=9"
        },
        {
            "title": "Intelence 100mg EUPI 04Mar2015 v1601-16x80-105-04-13.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025081&Seq=003&Type=9"
        },
        {
            "title": "[打樣版]PI_Intelence Tab 100mg_EUPI Mar2013_v1403-104-09-27(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025081&Seq=004&Type=9"
        },
        {
            "title": "020250810001-103-11-11.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025081&Seq=002&Type=9"
        },
        {
            "title": "PI of Intelence tablets___20121212.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025081&Seq=001&Type=9"
        },
        {
            "title": "1571-104-12-23(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025081&Seq=006&Type=8"
        },
        {
            "title": "1569-104-12-23(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025081&Seq=005&Type=8"
        },
        {
            "title": "1568-104-12-23(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025081&Seq=004&Type=8"
        },
        {
            "title": "1567-104-12-23(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025081&Seq=003&Type=8"
        },
        {
            "title": "1566-104-12-23(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025081&Seq=002&Type=8"
        },
        {
            "title": "1565-104-12-23(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025081&Seq=001&Type=8"
        }
    ]
}